We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.15B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
-4.94%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$4.31B
AUM Growth
-$2.67B
Cap. Flow
-$2.28B
Cap. Flow %
-53.06%
Top 10 Hldgs %
90.42%
Holding
26
New
–
Increased
3
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
AKRO
Akero Therapeutics
AKRO
+$82.8M
2
IMCR icon
Immunocore
IMCR
+$38.2M
3
PHVS icon
Pharvaris
PHVS
+$36.5M

Top Sells

Rank Stock Value
1
ESMT
EngageSmart, Inc.
ESMT
+$2.07B
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$312M
3
YOU icon
Clear Secure
YOU
+$41.9M
4
FUTU icon
Futu Holdings
FUTU
+$16.9M
5
MBLY icon
Mobileye
MBLY
+$3.52M

Sector Composition

Rank Sector Weight
1 Technology 43.6%
2 Healthcare 22.69%
3 Financials 17.65%
4 Industrials 10.64%
5 Consumer Staples 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLO icon
1
dLocal
DLO
$4.34B
$939M 21.82%
63,906,695
– –
XP icon
2
XP
XP
$8.5B
$760M 17.65%
29,617,733
– –
ALKT icon
3
Alkami Technology
ALKT
$1.96B
$460M 10.69%
18,729,806
– –
HRT
4
DELISTED
HireRight Holdings Corporation
HRT
$458M 10.64%
32,109,898
– –
SQSP
5
DELISTED
Squarespace, Inc.
SQSP
$387M 8.98%
10,611,073
– –
ALHC icon
6
Alignment Healthcare
ALHC
$3.73B
$303M 7.03%
60,993,323
– –
PHVS icon
7
Pharvaris
PHVS
$2.34B
$174M 4.04%
7,531,252
+1,375,000
+22% +$36.5M
EWCZ
8
DELISTED
European Wax Center
EWCZ
$170M 3.95%
13,110,492
– –
AKRO
9
DELISTED
Akero Therapeutics
AKRO
$132M 3.07%
5,233,989
+3,448,275
+193% +$82.8M
CNTA
10
DELISTED
Centessa Pharmaceuticals
CNTA
$109M 2.54%
9,681,818
– –
IMCR icon
11
Immunocore
IMCR
$1.7B
$97.9M 2.27%
1,506,684
+556,684
+59% +$38.2M
HCM icon
12
HUTCHMED
HCM
$1.96B
$67.2M 1.56%
4,000,000
– –
BLND icon
13
Blend Labs
BLND
$433M
$62.2M 1.44%
19,132,440
– –
RPRX icon
14
Royalty Pharma
RPRX
$26.6B
$45.6M 1.06%
1,500,000
– –
MBLY icon
15
Mobileye
MBLY
$2.04B
$38.4M 0.89%
1,194,839
-123,943
-9% -$3.52M
RSKD icon
16
Riskified
RSKD
$731M
$28.8M 0.67%
5,324,998
– –
THRD
17
DELISTED
Third Harmonic Bio
THRD
$27.9M 0.65%
2,958,762
– –
SLRN
18
DELISTED
ACELYRIN
SLRN
$19.5M 0.45%
2,889,668
– –
OPEN icon
19
Opendoor
OPEN
$3.77B
$19.2M 0.44%
6,532,236
– –
LOGC
20
DELISTED
ContextLogic
LOGC
$3.47M 0.08%
609,616
– –
GROV icon
21
Grove Collaborative
GROV
$45.8M
$1.56M 0.04%
936,020
– –
ADAG
22
Adagene
ADAG
$245M
$739K 0.02%
264,000
– –
FUTU icon
23
Futu Holdings
FUTU
$14.4B
– –
-309,255
Closed -$16.9M
YOU icon
24
Clear Secure
YOU
$5.71B
– –
-2,028,797
Closed -$41.9M
KRTX
25
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-986,710
Closed -$312M
1
2

Similar funds

NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.16B AUM 18.08% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

General Atlantic's Q1 2024 Portfolio in Review

As of Q1 2024, General Atlantic held 26 positions worth $4.31B, down 38% from $6.97B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

General Atlantic withdrew a net $2.28B in Q1 2024, closing 4 positions and reducing 1 holding. Its most notable exit was EngageSmart, Inc., an estimated $2.07B position sold in full.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 59% a quarter earlier, followed by Healthcare and Financials.

Against the trend, General Atlantic added an estimated $82.8M to Akero Therapeutics.

  • General Atlantic added most to Akero Therapeutics in Q1 2024, an estimated $82.8M increase.
  • General Atlantic's biggest Q1 2024 reduction was Mobileye, cutting an estimated $3.52M.
  • General Atlantic fully exited EngageSmart, Inc. in Q1 2024, selling an estimated $2.07B.
  • General Atlantic's ten largest holdings make up 90% of its $4.31B portfolio in Q1 2024.
  • General Atlantic opened 0 new positions and closed 4 in Q1 2024.
  • General Atlantic's portfolio value fell 38% quarter-over-quarter to $4.31B.

Based on General Atlantic's 13F filing for Q1 2024, filed 15 May 2024.